NSCLC Stage IV Without EGFR/ALK Mutation
5 clinical trials · Condition
◉ Watch NSCLC Stage IV Without EGFR/ALK Mutation
| Record | Firm | Date |
|---|---|---|
| Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung (NCT03808662) | Memorial Sloan Kettering Cancer Center | 2019-01-16 |
| Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer (NCT06207292) | Radiotherapy Oncology Centre "Santa Maria" Hospital | 2016-12-01 |
Track NSCLC Stage IV Without EGFR/ALK Mutation automatically
Every clearance here is in the API, with alerts when new ones post.